NSC64431
dc.creator | US National Cancer Institute | en_GB |
dc.date.accessioned | 2005-08-23T15:56:15Z | |
dc.date.available | 2005-08-23T15:56:15Z | |
dc.date.created | 2003-02-01 | en_GB |
dc.date.issued | 2005-08-23T15:56:15Z | |
dc.identifier | NSC64431 | en_GB |
dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/59235 | |
dc.format.extent | 12212 bytes | |
dc.format.mimetype | chemical/x-cml | |
dc.language.iso | en_GB | |
dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
dc.title | NSC64431 | en_GB |
dc.title.alternative | Butanoic acid, 2-[[[[[4-(dimethylamino)-1,4,4a,5,5a,6,11, 12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1, 11-dioxo-2-naphthacenyl]carbonyl]amino]methyl]amino]-4-(methylsulf inyl)-, monosodium salt | en_GB |
dc.title.alternative | Butyric acid, 2-[[[4-(dimethylamino)-1,4, 4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1, 11-dioxo-2-naphthacene-carboxamido]methyl]amino]-4-(methylsulfinyl )-, sodium salt | en_GB |
dc.type | Chemical Structures | en_GB |
dc.identifier.inchikey | VEVNLCDMYKUCCC-XYIGILHVSA-N | |
dc.identifier.inchi | InChI=1S/C28H35N3O11S/c1-27(40)12-6-5-7-16(32)17(12)21(33)18-13(27)10-14-20(31(2)3)22(34)19(24(36)28(14,41)23(18)35)25(37)30-11-29-15(26(38)39)8-9-43(4)42/h5-7,13-15,20,29,32,34-35,40-41H,8-11H2,1-4H3,(H,30,37)(H,38,39)/t13-,14+,15+,20+,27+,28-,43-/m0/s1 | |
dc.identifier.ichi | C28H35N3O11S,1H3-27(41H)12-6H-5H-7H-13(37H)14(12)17(32)16-20(39H)28(42H)19(33)15(18(38H)26H(31(2H3)3H3)25H(28)10H2-23H(16)27)21(34)29H-11H2-30H-24H(22(35)40H)8H2-9H2-43(4H3)36 | en_GB |
Files in this item
This item appears in the following Collection(s)
-
WWMM
The WorldWideMolecularMatrix, an Open collection of information on small molecules